BackgroundThe incidence of otitis media in children with bronchiolitis obliterans syndrome (BOS) was significantly higher than that of children with BOS without BOS. This study aims to compare the effect of Ciprofloxacin and the active pharmaceutical ingredient (API) in the treatment of children with BOS. Methods: This is a retrospective cohort study. Methods: We performed a retrospective review of patients with BOS who had a mean age of 12 years and a mean time from the diagnosis of BOS to the initiation of antibiotic therapy. The diagnosis of BOS was made by the diagnosis of acute otitis media (AOM) and bacterial otitis. The patients who were treated with Ciprofloxacin and active pharmaceutical ingredient (API) were followed for a mean period of 5.4 years. Results: A total of 5,976 children with AOM were included in the study. The patients with BOS who were treated with Ciprofloxacin and active pharmaceutical ingredient (API) were significantly more likely to have a history of AOM than the patients who were treated with BOS. Ciprofloxacin was found to be associated with a significantly higher risk of AOM in patients with BOS than in those without BOS. Conclusions: AIM: The incidence of AOM was significantly higher in children with BOS than in those with other forms of BOS. Therefore, the use of Ciprofloxacin should be avoided in children with AOM. Future studies are needed to evaluate the efficacy of Ciprofloxacin and the active pharmaceutical ingredient (API) in treating children with BOS.
The price of Ciprofloxacin USP 500 mg/tablet is$0.15 per tabletfor a supply of$150 for a supply of 14 tablets.
Ciprofloxacin USP 500 mg/tablet is used for:
For more information on Ciprofloxacin USP, please see the
Manufacturer License
Pfizer Inc.
Copyright © 2013 Pfizer Inc. All rights reserved. This medicine is available without a prescription from the manufacturer.
Ciprofloxacin USP is an antibiotic. It belongs to a group of antibiotics known as fluoroquinolones. It works by stopping the growth of bacteria. The bacteria in your body need time to develop and build up a enough strength to resist infection.In addition, Ciprofloxacin USP 500 mg/tablet is also used to treat other bacterial infections including:
Ciprofloxacin USP 250 mg/tablet is an antibiotic. It works by killing or stopping the growth of bacteria.For more information on Ciprofloxacin USP 500 mg/tablet, please see the
Ciprofloxacin USP 500 mg/tablet is an antibiotic.For more information on Ciprofloxacin USP 500 mg/tablet, see theCopyright by the American Medical Association.
Copyright by the American Society of Addiction Medicine.
Copyright by the National Association of Boards of Pharmacy.
Treatment of bacterial infections of the lungs, nose, ear, bones and joints, skin and soft tissue, kidney, bladder, abdomen, and genitals caused by ciprofloxacin-susceptible organisms. Infections may include urinary tract infection, prostatitis, lower respiratory tract infection, otitis media (middle ear infection), sinusitis, skin, bone and joint infections, infectious diarrhea, typhoid fever, and gonorrhea.
May be taken with or without food. May be taken w/ meals to minimise GI discomfort. Do not take w/ antacids, Fe or dairy products.
Hypersensitivity to ciprofloxacin or other quinolones. History or risk of QT prolongation; known history of myasthenia gravis. Concomitant use with tizanidine.
Vomiting, Stomach pain, Nausea, Diarrhea
Patient with known or suspected CNS disorders, risk factors predisposing to seizures, or lower seizure threshold; history or risk factors for QT interval prolongation, torsades de pointes, uncorrected hypokalaemia/hypomagnesaemia, cardiac disease (e.g. heart failure, MI, bradycardia); positive family history of aneurysm disease, pre-existing aortic aneurysm or dissection and its risk factors (e.g. Marfan syndrome, vascular Ehlers-Danlos syndrome, hypertension, peripheral atherosclerotic vascular disease); diabetes, previous tendon disorder (e.g. rheumatoid arthritis), G6PD deficiency. Renal and hepatic impairment. Elderly, children. Pregnancy and lactation.
Store between 20-25°C.
Quinolones
Use only afterMEDS gastrointestinal DisorderPrecautionarate medical history and laboratory tests. Education should be conducted according to theMEDSgastrointestinal Disorder (gastro-resistant) Education should include: 1. Medical History and Childahl-Zegeruski classification. 2. History and predisposing factors. 3. Monitoring. 4. Advice for the safety of use. 5. Storage control. See PRECAUTIONS.Be aware that ciprofloxacin is excreted in breast milk. Potential risks to fetal development are unknown. Patients with kidney or liver impairment should commence treatment with ciprofloxacin. Do not take w/ dairy products.
Administration to be considered for use in low birth weight and for use in pregnancy with normal liver function. Ciprofloxacin should be used with caution in patients with hepatic impairment. Avoid use during the last trimester of pregnancy. Neonates with a history of gynaecological infections or pelvic inflammatory disease (e.g. cellulitis, staphylococcal haematitis, leprosy, amebiasis, intestinal amebiasis, protozoal infections, bone and joint infections, infectious diarrhea, typhoid fever, and gonorrhea). Known or suspected congenital adrenalBloombergliasis, drug hypersensitivity, adrenal hyperplasia, hypertriglyceridemia, or other clinical features of hypercholesterolemia. If you are breast-feeding or planning to breastfeed, it is recommended to inform your physician.
Ciprofloxacin Tablets 100 mg are for the treatment of bacterial infections in the lungs, nose, ear, and throat. These medicines are not recommended for use in children under 12 years of age, in patients with a history of asthma, severe reflux disease (Reflux), ulcers in the throat or oesophagus, severe infections in the esophagus (gum) (genital tract), or other reasons. Treatment with Ciprofloxacin Tablets 100 mg may lead to the death of the patient. Treatment with Ciprofloxacin Tablets 100 mg should only be administered to pregnant women and lactationers as advised by their doctor. It is not known if this medicine is compatible with your medicines and if so, what dose and dose instructions are given.
USES OF Ciprofloxacin TABLETS 100 mg
How to use Ciprofloxacin Tablets 100 mg
Ciprofloxacin Tablets 100 mg are used for the treatment of bacterial infections in the lungs, nose, ear, and throat.
HOW TO USE Ciprofloxacin Tablets 100 mg is as follows:
Take Ciprofloxacin Tablets 100 mg exactly as prescribed by your doctor. Follow all directions on your prescription label and read the enclosed leaflet before use. Do not exceed the prescribed dosage. Swallow Ciprofloxacin Tablets with a glass of water.
Tell your doctor if your symptoms do not improve within a few days. Ciprofloxacin Tablets 100 mg are for adults and children from 12 years of age and weighing between 177 to 250g.
The course of treatment with Ciprofloxacin Tablets 100 mg is three days and up to five days a person should complete the course.
If you forget to take a dose, take it as soon as you remember, unless it is almost time for the next dose. In that case, skip the forgotten dose and take the next dose at the regular time. Do not take a double dose to make up for a missed one. If you take more Ciprofloxacin Tablets 100 mg than you should, talk to your doctor about the next dose.
Cipro, the brand name for ciprofloxacin, is a fluoroquinolone antibiotic used primarily for the treatment of bacterial infections, including respiratory tract infections, skin and soft tissue infections, urinary tract infections, and gonorrhea. Ciprofloxacin is sold under a variety of brand names, including Ciprodex, CiproQ, and CiproJ. Ciprofloxacin is classified as a tetracycline antibiotic, effective against both gram-positive and gram-negative bacteria. It is used in the treatment of infections caused by susceptible bacteria, such as pneumonia, bronchitis, and infections of the skin and soft tissue. It may also be used to treat infections caused by gram-positive bacteria such as those caused by Escherichia coli, Klebsiella pneumoniae, and Enterococcus faecalis. Ciprofloxacin is used to treat bacterial infections of the skin and soft tissue. It is also used to treat infections caused by Streptococcus pneumoniae and other strains of bacteria.
Ciprofloxacin (Cipro) for sale (Nippon Pharma)Ciprofloxacin (Cipro) is used to treat a wide range of bacterial infections, including:
Ciprofloxacin (Cipro) is used for the treatment of different types of bacterial infections:
Ciprofloxacin (Cipro) is used to treat other bacterial infections as well.
Ciprofloxacin (Cipro) is used to treat other types of bacterial infections as well.
Ciprofloxacin (Cipro) is used for the treatment of bacterial infections.
Product name:CIPRO XR 500MG TAB
Company name:
DIN:02247903
Status:Marketed
Status date:2021-03-29
| Active ingredient(s) | Strength |
|---|---|
| 500 MG |
Click on a resource to visit a page with more information. You may be taken away from this page to a different Government of Canada website.
For consumers| Resource | Description |
|---|---|
The Product Monograph is a scientific document that describes the properties, claims, indications and conditions of use of the product and contains any other information that may be required for optimal, safe and effective use. The Product Monograph includes three sections:
| |
Side effects are troublesome symptoms or feelings that you may not expect that show up when you are taking a medicine. All suspected side effects should be reported, especially those that are:
|
Section C.01.020.1 of the Food and Drug Regulations and section 62 of the Medical Devices Regulations, require hospitals to report to Health Canada all serious adverse drug reactions (ADRs) and medical device incidents (MDIs) within 30 days of being documented within the hospital. This regulatory requirement only applies to hospitals. |
| After Health Canada completes the regulatory review process for a product, the clinical information included in a submission is made publicly available for non-commercial purposes. |
Stade de France Pharmacy